Tissue peptides
LL-37
- 5 mg
Custom strengths on request
Not FDA-approved. Not on FDA's 503A category lists (May 14, 2026). Source, May 14, 2026
At a glance
These dosages are a helpful guide, not a prescription. Every clinician is expected to do their own due diligence before prescribing.
Start
0.5 mg/mL, topical application to venous leg ulcer
Human study
- Frequency
- Twice weekly
- Route
- Topical application to ulcer
- Course
- 4-week randomized treatment phase
All human doses are topical or intratumoral; none supports a subcutaneous dose, and the phase IIb trial did not reproduce the healing signal.
Get a quote
Custom strengths on request. Prices are quoted per clinic.